Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Tucker

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Structural & Molecular Biology|September 20, 2024
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growthYing Zhang, Kaijing Chen, Seng Chuan Tang, et al.
Nature|July 6, 2007
A transforming mutation in the pleckstrin homology domain of AKT1 in cancerJohn D Carpten, Andrew L Faber, Candice Horn, et al.
The Journal of Cell Biology|August 4, 2021
TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelinationWan Yun Ho, Jer-Cherng Chang, Kenneth Lim, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2Kamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.
Elife|February 13, 2019
Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axisShuo-Chien Ling, Somasish Ghosh Dastidar, Seiya Tokunaga, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent KinasesKamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.
BMC Cancer|February 4, 2023
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular CarcinomaAh-Jung Jeon, Yue-Yang Teo, Karthik Sekar, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Structural & Molecular Biology|September 20, 2024
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growthYing Zhang, Kaijing Chen, Seng Chuan Tang, et al.
Nature|July 6, 2007
A transforming mutation in the pleckstrin homology domain of AKT1 in cancerJohn D Carpten, Andrew L Faber, Candice Horn, et al.
The Journal of Cell Biology|August 4, 2021
TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelinationWan Yun Ho, Jer-Cherng Chang, Kenneth Lim, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2Kamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.
Elife|February 13, 2019
Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axisShuo-Chien Ling, Somasish Ghosh Dastidar, Seiya Tokunaga, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent KinasesKamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.
BMC Cancer|February 4, 2023
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular CarcinomaAh-Jung Jeon, Yue-Yang Teo, Karthik Sekar, et al.
Pageof 4